NCT07068230View on ClinicalTrials.gov

Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

October 1, 2019

Conditions
Postdural Puncture HeadachePostoperative Nausea and VomitingObstetric Anesthesia Problems
Interventions
DRUG

Ondansetron 8mg

Ondansetron 8 mg IV Administered 5 minutes before spinal anesthesia

DRUG

Dexamethasone

Dexamethasone 8 mg IV Administered 5 minutes before spinal anesthesia

DRUG

Saline

5ml normal saline Administered 5 minutes before spinal anesthesia

Trial Locations (1)

Unknown

El-Minia University Hospital, Minya

All Listed Sponsors
collaborator

Faculty of Medicine, Minia University

UNKNOWN

lead

Minia University

OTHER

NCT07068230 - Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting | Biotech Hunter | Biotech Hunter